Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
8.36
+0.22 (2.70%)
Nov 21, 2024, 12:19 PM EST - Market open
Iovance Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,540 | 2,081 | 1,009 | 2,995 | 6,806 | 3,493 | |
| Market Cap Growth | 152.80% | 106.29% | -66.33% | -55.99% | 94.85% | 220.45% | |
| Enterprise Value | 2,162 | 1,799 | 729 | 2,491 | 6,103 | 3,146 | |
| Last Close Price | 8.14 | 8.13 | 6.39 | 19.09 | 46.40 | 27.68 | |
| PS Ratio | 24.88 | 1749.89 | - | - | - | - | |
| PB Ratio | 3.21 | 3.56 | 2.02 | 4.82 | 10.37 | 11.68 | |
| P/TBV Ratio | 6.11 | 5.86 | 2.02 | 4.82 | 10.37 | 11.68 | |
| EV/Sales Ratio | 23.80 | 1512.80 | - | - | - | - | |
| Debt / Equity Ratio | 0.10 | 0.13 | 0.17 | 0.12 | 0.08 | 0.04 | |
| Asset Turnover | 0.10 | 0.00 | - | - | - | - | |
| Quick Ratio | 3.84 | 2.54 | 5.16 | 5.65 | 11.47 | 7.86 | |
| Current Ratio | 4.22 | 2.79 | 5.24 | 5.69 | 11.59 | 8.10 | |
| Return on Equity (ROE) | -56.65% | -81.91% | -70.61% | -53.55% | -54.34% | -51.64% | |
| Return on Assets (ROA) | -29.15% | -39.86% | -34.59% | -27.71% | -29.41% | -31.33% | |
| Return on Capital (ROIC) | -33.47% | -46.22% | -39.01% | -30.57% | -32.14% | -33.29% | |
| Earnings Yield | -16.53% | -21.34% | -39.25% | -11.43% | -3.81% | -5.66% | |
| FCF Yield | -15.08% | -18.46% | -31.05% | -8.86% | -3.70% | -4.75% | |
| Buyback Yield / Dilution | -30.80% | -47.64% | -3.82% | -10.92% | -11.23% | -27.82% | |
| Total Shareholder Return | -30.80% | -47.64% | -3.82% | -10.92% | -11.23% | -27.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.